There is proposed a chemical compound of 5,11,17,23-tetrakis[bis(dihydroxyphosphoryl)methyl]calix[4]arene and a sodium salt thereof, which can be used as antithrombotic agents. A highly specific inhibiting effect of the aforementioned calixarenes on the fibrin polymerization has been identified. It has been found that the addition of the aforementioned calixarenes to blood plasma leads to an increase of the prothrombin time and the activated partial thromboplastin time.
提出了一种
化学化合物,即5,11,17,23-四(双羟基
磷酰基)甲基]卡利克斯[4]
芳烃及其钠盐,可用作抗血栓药物。已确定上述卡利克斯
芳烃对
纤维蛋白聚合的高度特异性抑制作用。发现将上述卡利克斯
芳烃添加到血浆中会导致凝血酶原时间和活化部分凝血活酶时间的增加。